Table 1 Baseline characteristics of patients in the transaortic group, transseptal group and trans-DGCV group
Group | Male gender | Age, years | Disease duration, years | PVC count (number/24 h) | Hypertension | Diabetes | LV enlargement | NSVT | PVCs |
|---|---|---|---|---|---|---|---|---|---|
Transaortic (n = 22) | 11 (50.0) | 55.5 ± 18.8 | 3.06 ± 2.37 | 26129 ± 10200 | 9 (40.9) | 1 (4) | 8 (36.4) | 5 | 17 (77.3) |
Transseptal (n = 10) | 6 (60.0) | 59.7 ± 15.8 | 2.80 ± 2.24 | 25025 ± 10078 | 5 (50.0) | / | 3 (30.0) | 3 | 7 (70.0) |
Trans-DGCV (n = 13) | 7 (53.8) | 56.1 ± 13.7 | 2.79 ± 2.35 | 29543 ± 14197 | 5 (38.5) | / | 4 (30.8) | 4 | 9 (69.2) |